XML 25 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue $ 32,634 $ 20,398
Cost of revenues 8,084 6,035
Gross Margin 24,550 14,363
Operating Expenses:    
General and administrative 11,348 8,674
Selling and marketing 6,323 4,898
Research and development 673 579
Depreciation and amortization 789 752
Total Operating Expenses 19,133 14,903
Operating Income (Loss) 5,417 (540)
Other Income (Expense)    
Change in fair value of derivative liabilities (31,413) (9,621)
Gain on extinguishment of debt 6,326 0
Other expense (893) (19)
Other income 2,855 0
Total Other Expense (36,762) (25,263)
Net Loss Before Income Taxes (31,345) (25,803)
Income tax expense 27 4
Net Loss [1] (31,372) (25,807)
Other Comprehensive Loss    
Foreign currency translation adjustments 121 (44)
Total Comprehensive Loss $ (31,251) $ (25,851)
Net Loss per share:    
Basic (in dollars per share) [2] $ (7.03) $ (12.19)
Diluted (in dollars per share) [2] $ (7.03) $ (12.19)
Weighted average shares outstanding:    
Basic (in shares) [2] 4,462,883 2,116,936
Diluted (in shares) [2] 4,462,883 2,116,936
Nonrelated Party    
Other Income (Expense)    
Interest expense $ (12,423) $ (12,946)
Related Party    
Other Income (Expense)    
Interest expense $ (1,214) $ (2,677)
[1] Reflects a one-for-three hundred seventy-five (1:375) reverse stock split of the outstanding shares of the Company's common stock effected on October 18, 2024.
[2]
* Reflects a one-for-three hundred seventy-five (1:375) reverse stock split of the outstanding shares of the Company's common stock effected on October 18, 2024.